Operating Expenses

Other Operating Income

Edwards Lifesciences Other Operating Income decreased by 0.7% to $14.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.7%, from $19.10M to $14.20M.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2016
Last reportedQ1 2026May 6, 2026
Metric ID: mu_other_operating_income_expense_net

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00-$22.40M$22.70M$19.10M$21.30M$12.50M$14.30M$14.20M
QoQ Change+201.3%-15.9%+11.5%-41.3%+14.4%-0.7%
YoY Change+155.8%-37.0%-25.7%
Range-$22.40M$22.70M
Avg YoY Growth+31.0%
Median YoY Growth-25.7%

Other Operating Income at Other Companies

Frequently Asked Questions

What is Edwards Lifesciences's other operating income?
Edwards Lifesciences (EW) reported other operating income of $14.20M in Q1 2026.
How has Edwards Lifesciences's other operating income changed year-over-year?
Edwards Lifesciences's other operating income decreased by 25.7% year-over-year, from $19.10M to $14.20M.